The Biden administration is moving to designate new panelists to a long-awaited forum for resolving drug discount fights after it nixed Trump-era appointees earlier this year, a step that had effectively halted the dispute process.
The Department of Health and Human Services is considering “recommended new appointments” to “correct for shortcomings in the prior slate of appointments” made by the Trump administration, according to a court document filed by the National Association of Community Health Centers and the government.
The filing is the latest in a lawsuit NACHC brought against the HHS in October 2020, to force the agency to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.